General Information of the Compound
| Compound ID |
CP0505216
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
methyl 2-[4-[[(2R)-3-(7-methyl-1H-indazol-5-yl)-1-oxo-1-(4-piperidin-1-ylpiperidin-1-yl)propan-2-yl]carbamoyl]piperazin-1-yl]benzoate
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C34H45N7O4
|
||||||||||||||||||
| Molecular Weight |
615.779
|
||||||||||||||||||
| Canonical SMILES |
COC(=O)c1ccccc1N1CCN(CC1)C(=O)N[C@H](Cc1cc(C)c2[nH]ncc2c1)C(=O)N1CCC(CC1)N1CCCCC1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C34H45N7O4/c1-24-20-25(21-26-23-35-37-31(24)26)22-29(32(42)40-14-10-27(11-15-40)38-12-6-3-7-13-38)36-34(44)41-18-16-39(17-19-41)30-9-5-4-8-28(30)33(43)45-2/h4-5,8-9,20-21,23,27,29H,3,6-7,10-19,22H2,1-2H3,(H,35,37)(H,36,44)/t29-/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
NMHCVXFCRULPKG-GDLZYMKVSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound